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Calcium (Ca2+) plays several fundamental roles in regulating diverse neural 
processes such as membrane excitability and synaptic transmission, and 
perturbed calcium homeostasis in neurons are implicated in neurodegenerative 
diseases including Alzheimer’s disease (AD). The calcium homeostasis 
modulator 1(CALHM1) is a leaky Ca2+ channel that is localized mainly at the 
endoplasmic reticulum (ER) and plasma membrane (PM) and is known to 
modulate the intracellular Ca2+ signals. The single nucleotide polymorphism 
(SNP) of the CALHM1-P86L (rs2986017) was reported to be associated with 
AD yet this association is still controversial.  
ii 
 
There are two other CALHM family proteins, CALHM2 and CALHM3; 
however their functional properties remain unknown. As CALHM family 
proteins share sequence homology and similar structures, we hypothesized 
that CALHM family subtypes interact with each other and subsequently their 
interaction affects their function.  
Here, we showed that CALHM2 and CALHM3 are localized at the ER 
membrane and form novel Ca2+ channels through mutual interaction as well 
as their expression in the mouse brain. We found that although CALHM1 
and CALHM3 are leaky Ca2+ channels, CALHM2 is inactive by itself and 
CALHM2 regulates CALHM1 and CALHM3 channel activities when 
constitutes heteromeric channels with them. These results suggest that 
CALHM family members may exist as heteromeric Ca2+ channels in the 
brain and contribute to the regulation of intracellular Ca2+ homeostasis 
Key words: Calcium homeostasis, CALHM (Calcium homeostasis 
modulator) family, Alzheimer’s disease, Ca2+ channel 
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Calcium (Ca2+) is implicated in diverse neural processes such as membrane 
excitability, synaptic transmission, gene expression, and cell death and is 
important for executing higher brain functions. Therefore, perturbation in 
neuronal Ca2+ homeostasis is thought to cause diverse neurodegenerative 
diseases including Alzheimer’s disease (AD) (Bezprozvanny and Mattson 
2008; Marambaud, Dreses-Werringloer et al. 2009; Berridge 2010). Many 
studies have shown that AD causing mutations of amyloid precursor protein 
(APP) and presenilins (PS) are associated with perturbed intracellular Ca2+ 
signaling, which is caused by dysregulation of various Ca2+ channels and 
pumps on the plasma membrane (PM) and endoplasmic reticulum (ER) 
membrane (LaFerla 2002; Smith, Green et al. 2005; Supnet and 
Bezprozvanny 2010). 
Recently, calcium homeostasis modulator 1 (CALHM1, previously 
annotated as FAM26C), a Ca2+ permeable channel, was reported in 
influencing Ca2+ homeostasis, Aβ levels, and AD risks (Dreses-Werringloer, 
Lambert et al. 2008; Boada, Antunez et al. 2010; Cui, Zheng et al. 2010). 
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CALHM1 is a multipass transmembrane glycoprotein and that is localized 
mainly at the ER membrane and partially at the PM. Overexpression of 
CALHM1 decreases extracellular Aβ accumulation and elevates sAPPα level 
in APP-transfected mouse neuroblastoma N2a cells (Dreses-Werringloer, 
Lambert et al. 2008). In addition, CALHM1 increases intracellular and 
mitochondrial Ca2+ concentration and reduces ER Ca2+-contents by decreasing 
both the transport capacity and the Ca2+ affinity of the sarco/endoplasmic 
reticulum Ca2+-ATPase (SERCA), which causes ER stress (Dreses-
Werringloer, Lambert et al. 2008; Moreno-Ortega, Ruiz-Nuno et al. 2010; 
Gallego-Sandin, Alonso et al. 2011).  
It has been suggested that the P86L, single nucleotide polymorphism (SNP) 
of the CALHM1 is associated with AD (Dreses-Werringloer, Lambert et al. 
2008; Boada, Antunez et al. 2010; Cui, Zheng et al. 2010) but other studies 
failed to find such association (Inoue, Tanaka et al. 2010; Shibata, Kuerban et 
al. 2010; Feher, Juhasz et al. 2011). Although the role of CALHM1 in AD is 
controversial, CALHM1-P86L shows impaired channel activity of CALHM1 
(Dreses-Werringloer, Lambert et al. 2008; Moreno-Ortega, Ruiz-Nuno et al. 
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2010).    
Besides CALHM1, there are two other members among the CALHM 
family proteins, CALHM2 (FAM26B) and CALHM3 (FAM26A). However, 
little is known about them. One Japanese group studied about the SNPs in all 
genes of the CALHM family and reported no detectable association of the 
SNPs of the three genes with AD (Shibata, Kuerban et al. 2010). The 
expression of CALHM family proteins in TRPM5-positive taste cells was also 
reported, although their physiological functions in taste signaling were 
unknown (Moyer, Hevezi et al. 2009).  
CALHM1 has sequence similarities with the selectivity filter of the NMDA 
receptor (Dreses-Werringloer, Lambert et al. 2008). NMDA receptors have 
several subtypes that have differences in sensitivity to ligands, permeation and 
blockage by divalent ions and kinetics and their functional properties are 
determined by subunit composition (Cull-Candy, Brickley et al. 2001), 
Waxman and Lynch 2005). In addition, CALHM2 and CALHM3 share 
sequence homology with CALHM1. Thus we hypothesized that CALHM 
subtypes interact with each other and their functions might be modulated by 
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mutual interaction, similar to the actions of NMDA receptor. 
In the present study, we first examined functional properties of CALMH2 
and CALHM3 as Ca2+ channels. We also examined whether CALHM 
subtypes constituted of heteromeric channels that modulate the functional 
properties of the channels. Our results demonstrate that CALHM3 is a leaky 
Ca2+ channel as similar to CALHM1, whereas CALHM2 is not permeable for 
Ca2+ by itself. In addition, we found that CALHM subtypes interact with each 
other and that their mutual interaction modulates the functional properties of 
the channels. Our findings suggest that CALHM family members may exist as 
heteromeric Ca2+ channels to modulate Ca2+ homeostasis in the brain.  
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MATERIALS AND METHODS 
Animals 
All animal experiments were performed in accordance with the RIKEN 
guidelines for animal experiments. 
 
Cell culture and transfection 
HeLa cells and HEK293T cells were obtained from the RIKEN Cell Bank 
(Tsukuba, Japan). All cell lines were cultured in Dulbecco’s modified Eagle’s 
medium (Nakarai Tesque, Kyoto, Japan) supplemented with 10% heat-
inactivated fetal bovine serum, 100 units/ml penicillin, and 0.1 mg/ml 
streptomycin (Nakarai Tesque). Transfections of DNAs were performed using 




Human CALHM1 cDNAs in the pcDNA3.1 Myc-His vector were generously 
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recived from Dr. Philippe Marambaud. These cDNAs restricted with EcoRI 
and XhoI and transferred into pEGFP-N1 vector (Clontech, CA, USA). 
Human CALHM2 and CALHM3 were amplified by PCR using the primers 
5’-GGCTCGAGATGGCAGCCCTGATCGCAGAG-3’and 5’- CCGAATTC 
CGGAGGGGAGCAGGGCCATCTC-3’ for CALHM2 and 5’-GGAAGCTT 
ATGGATAAATTCCGATGCTC-3’ and 5’-CCGAATTCCCACGTCGGTG 
TGTTGTGACAG-3’ for CALHM3 (the underlined letters indicate restriction 
enzyme site) and a HeLa cell cDNA as a template. The PCR fragments were 
digested by appropriate restriction enzymes and cloned into pEGFP-N1 and 
pcDNA3.1 Myc-His C vector (Invitrogen, NY, USA). 
 
RT-PCR  
The specific primers used were: mouse CALHM1: CCGAATTC CTGGAAC 
TGGGTCATACCCACGG,GGCTCGAGTTAGCATTTGTGCCAGCTTGTG 
AG; mouse CALHM2: CCGAATTCAAGGATGACGAAGAGCTGGTCGC 
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C, GGCTCGAGTTAAGCAGTGAGCAGGGCCATCTCCACATTG; mouse 
CALHM3: CCGAATTCCGTGCCCTGGGGTTACGTCGGGAC, GGCTCG 
AGTTAGCTGGAGTACCAGGTACTGAGGAGTTG; GAPDH: ATACGGC 
TACAGCAACAGGGTG, CTCTCTTGCTCAGTGTCCTTG. The reactionus
ed was: 30 sec at 94˚C, 30 sec for 63˚C, 20 sec at 68˚ C for 40 cycles. Ten ng 
of cDNA from the individual parts of the mouse brain were used as a template. 
The amplified PCR fragments were cloned (underlines in the primer 




GST fusion proteins with the COOH-terminal region of each CALHM family 
protein were produced in E.coli and used as antigens. Rabbits were 
immunized with these antigens and complete Freund’s adjuvant by 
subcutaneous injection at 14-day intervals. All antibodies were affinity-
purified by passing the immunized rabbit’s serum through the CNBr-activated 
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Sepharose 4B (GE Health care AB, Sweden) column covalently coupled with 
MBP-CALHM family protein. Other antibodies used were: mouse anti-Myc 
antibody (9E10) (Santa Cruz Biotechnology Inc., CA, USA)), rabbit anti-
Calreticulin antibody (abcam, Tokyo, Japan), mouse anti-GFP antibody (MBL 
International Corporation, Nagoya, Japan), Alexa 594-conjugated goat anti-
rabbit IgG (Invitrogen, CA, USA) and Alexa 488-conjugated goat anti-mouse 
IgG (Invitrogen, CA, USA). 
 
Immunocytochemistry 
Transfected cells were fixed with 4% paraformaldehyde in PBS for 10 min, 
permeabilized with 0.2% Triton X-100 in PBS for 5 min, and blocked with 
1% skim milk with 1% normal goat serum (Vector Laboratories, CA, USA) in 
PBS for 1h at RT. Then they were incubated with primary antibody for 1h at 
RT, washed with PBS three times and incubated with secondary antibody for 
1h at RT. After washing with PBS three times, the coverslips were mounted 
with Vectashield containing 4’,6-diamidino-2-phenylindole (DAPI, Vector 
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Laboratories) and observed under a confocal fluorescence microscope 
(FV1000, Olympus, Tokyo, Japan). 
 
Co-immunoprecipitation 
HEK293T cells expressing CALHM family were solubilized in lysis buffer 
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40 and 
proteinase inhibitors). The homogenates were centrifuged at 15,000 rpm for 
10 min. Supernatants were incubated with 3 g of primary antibody and 30 μl 
of 50% protein G-Sepharose 4B Fast Flow (GE Healthcare AB, Sweden) for 
overnight at 4℃. The immuno-complexes were washed three times with lysis 
buffer and proteins were eluted by SDS polyacrylamide gel electrophoresis 
(SDS-PAGE) sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% 




Western Blotting  
Proteins were separated by SDS-PAGE and transferred to polyvinylidene 
difluoride membrane (Amersham Pharmacia, Buckinghamshire, United 
Kingdom). The membrane was blocked with 5% skim milk in PBST for 1h at 
RT and incubated with primary antibody for 1h at RT. After incubation, 
membrane were washed with PBST three times and incubated with 
horseradish peroxidase-conjugated secondary antibody (Amersham 
Pharmacia) for 1h at RT. After washed with PBST, immunoreactive bands on 
the membrane were visualized with Immobilon Western Detection Reagents 
(Millipore, MA, USA) and LAS-4000 mini (Fuji Film, Tokyo, Japan). 
 
Ca2+ imaging 
Intracellular Ca2+ imaging was performed as described previously (Higo, 
Hattori et al. 2005). After 12h of transfection, cells were loaded with 5 μM 
fura-2 AM (Dojindo, Japan) for 30 min at RT. Then, the cells were placed on 
the stage of an inverted microscope (IX-70; Olympus, Japan) and perfused 
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with HEPES-buffered salt solution (HBSS) (20 mM HEPES, 115 mM NaCl, 
5.4 mM KCl, 1 mM MgCl2, pH 7.4, 10 mM glucose and 2 mM CaCl2). Image 
was captured and processed with an Argus 50/CA system (Hamamatsu 
Photonics, Japan) at RT. Delta R (ΔR) is the change in the ratio (F340/F380) 
of the fluorescent intensities of fura-2AM that are excited by the light at a 
wavelength of 340 and 380 nm. For determining the amount of Ca2+ store size, 
cells were treated 10 μM cyclopiazonic acid (CPA; Sigma-Aldrich, Rehovot, 
Israel) under Ca2+ free HBSS (Bergner, Kellner et al. 2009). Before the 
imaging, GFP fluorescence images were acquired to identify the transfected 
cells. The Ca2+-increasing rate was calculated by amount of [Ca2+] i change   
divided by time (min). 
 
Statistical Analysis 
Statistical analysis was done using SPSS (Chicago, IL). Data were expressed 
as mean ± S.E. values. Student's t-test or One-way ANOVA followed by 
Tukey’s test and Least Significant Difference (LSD) test was used for 




CALHM subtypes share sequence homology and secondary 
structures.  
Typically, function of new proteins can be inferred from other proteins with 
similar sequences, since their common origin is assumed to be reflected in 
their structure and function (Abascal and Valencia 2003). For the protein 
structure and function prediction, we analyzed amino acid sequences of  
human CALHM family proteins using a multiple sequence alignment (Corpet 
1988). As shown in Figure 1, all CALHM family proteins showed relatively 
high consensus sequence (red: high (90%) consensus, blue: low (50%) 
consensus) and CALHM2 and CALHM3 showed about 44% and 22% 
identities with CALHM1.  
The predicted secondary structures are shown in Figure 2. CALHM2 has 
three transmembrane (TM) domains and CALHM3 has four TM domains 
similar to CALHM1. With these sequence homology and similar structures, 
we speculated that other CALHM family subtypes may also function as a Ca2+ 
channel like CALHM1.  
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CALHM subtypes bind to each other and constitute heteromeric 
channels.  
Although the expressions of CALHM1 at the ER and the PM were 
previously reported (Dreses-Werringloer, Lambert et al. 2008), there are no 
information for the intracellular localizations of CALHM2 and CALHM3. To 
examine the intracellular localization of each CALHM family proteins in cells, 
we first exogenously expressed each subtypes of CALHM family protein in 
HeLa cells and performed immunocytochemistry. We found that CALHM1 
was mainly localized at the ER and some of the signals were also observed at 
or near the PM as previously reported (Dreses-Werringloer, Lambert et al. 
2008) (Fig. 3A). We also found that CALHM2 and CALHM3 showed similar 
reticular expression patterns much like CALHM1 when expressed alone and 
were extensively co-localized with the ER resident protein, calreticulin 
(Figure 3A). To examine whether CALHM subtypes colocalized with each 
other in cells, we then expressed two subtypes of CALHM in HeLa cells and 
examined their intracellular localization. We found that the particular reticular 
expression pattern was also observed in the cells co-expressing two types of 
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CALHM family proteins and the two CALHM family protein signals were 
extensively co-localized with each other (Figure 3B). 
We next performed the co-immunoprecipitation assay using HEK293T cells 
transiently expressing two subtypes of CALHM family proteins to see if 
CALHM family proteins formed heteromeric channels. When we 
overexpressed CALHM1-myc and CALHM2-GFP and immunoprecipitated 
CALMH1-myc with anti-CALHM1 antibody, CALHM2-GFP was co-
immunoprecipitated as shown in Figure 3C. CALHM2 was not detected in the 
control anti-rabbit-IgG immunoprecipitates (Figure 3C). When we co-
transfected with CALHM2-myc and CALHM3-GFP and immunoprecipitated 
CALHM2-myc with anti-CALHM2 antibody, CALHM3-GFP was 
imunoprecipiated (Figure 3D). Interaction between CALHM1 with CALHM3 
was also confirmed in cells overexpressing CALHM3-myc and CALHM1-
GFP (Figure 3E). Similar results were obtained in HeLa cells transiently 
expressing CALHM family proteins (data not shown). These results suggested 
that CALHM family proteins heteromulitimerized at the ER and PM in vitro. 
１５ 
 
CALHM family subtypes are expressed in the brain.  
Whereas CALHM1 mRNA expression in the mouse brain was previously 
demonstrated (Dreses-Werringloer, Lambert et al. 2008), and the expression 
of CALHM2 and CALHM3 mRNA remains unknown. To examine the mRNA 
expressions of CALHM2 and CALHM3 in the brain, we performed RT-PCR 
with specific primers for each CALHM subtypes using cDNAs from various 
parts of the mouse brain as a template. We examined each subtypes of 
CALHM mRNA in cortex, hippocampus, striatum, and cerebellum, and 
confirmed the expression of all subtypes of CALHM mRNA in those brain 
regions (Figure 4). Thus, the result suggested that all CALHM subtypes are 
expressed in the brain. 
 
CALHM1 and CALHM3, but not CALHM2, form Ca2+ leaky 
homomeric channels.  
Although CALHM1 channel was shown to be a constitutively open Ca2+ 
channel at the PM and also worked as an ER Ca2+ leak channel (Moreno-
Ortega, Ruiz-Nuno et al. 2010; Gallego-Sandin, Alonso et al. 2011), the 
nature of CALHM2 and CALHM3 channel as a Ca2+ channel was still 
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unknown. To examine whether CALHM2 and CALHM3 could have Ca2+ 
channel properties by themselves, we overexpressed each CALHM family 
protein in HeLa cells and examined intracellular Ca2+ signals within the cells. 
Whereas only gradual elevation of intracellular Ca2+ concentration [Ca2+]i was 
observed in the control cells when we elevated extracellular Ca2+ 
concentration from 0 (nominally free) to 2 mM, the robust Ca2+ entry was 
detected in the GFP-tagged CALHM1 overexpressing cells in response to the 
stimulation as previously reported (Figure 5A).  
CALHM3-GFP overexpression also significantly increased Ca2+ entry as 
compared to the control cells, although the ratio change of [Ca2+]i was smaller 
than that of GFP-tagged CAHLM1 (Figure 5A and 5B). In contrast, GFP-
tagged CALHM2 expression did not significantly affect Ca2+ entry as 
compared to the control cells (Figure 5A-5C). The Ca2+-increasing rates were 
increased by about 70-fold and 2-fold in CALHM1 and CALHM3 expressing 
cells, respectively (Figure 5B). The ratio change of [Ca2+]i at the steady state 
also increased by 15-fold and 4-fold as compared control cells in CALHM1 
and CALHM3 expressing cells (Figure 5C). These results suggested that both 
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CALHM1 and CALHM3 were Ca2+ leaky channels, whereas CALHM2 could 
not function as a Ca2+ permeable channel by itself. 
 
Overexpression of CALHM1 and CALHM3 decreases Ca2+ content 
within the ER. 
It is known that overexpression of CALHM1 decreases Ca2+ concentration 
within the ER by increasing the rate of Ca2+ leaking from the ER and by 
reducing the ER Ca2+ uptake through the SERCA (Gallego-Sandin, Alonso et 
al. 2011). Therefore, we tested whether CALHM2 and CLAHM3 expression 
could affect ER Ca2+-content. In order to measure the ER Ca2+-content, we 
treated CALHM family transfected cells with 10 μM cyclopiazonic acid 
(CPA), an inhibitor for SERCA, in the nominal absence of external Ca2+ 
(Bergner, Kellner et al. 2009). As shown in Figure 6A, the CPA treatment 
induced a passive Ca2+ efflux from the ER and increased the [Ca2+]i in the 
cells. We calculated the area under curve (AUC) of the [Ca2+]i to estimate the 
Ca2+-contents of the ER for each CALHM family transfected cells (Figure 6B). 
As shown in Figure 6B, the Ca2+-contents of the ER of cells overexpressing 
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CALHM1 and CALHM3 were about 6-fold and 2-fold less than those of the 
control cells, respectively. In contrast, CALHM2 expression didn’t 
significantly affect the ER Ca2+-store size (Figure 6B). 
  
CALHM2 modified Ca2+ channel properties of CALHM1 and 
CALHM3. 
Since CALHM2 did not show apparent Ca2+ channel activity by itself and 
interacted with CALHM1 and CALHM3 (Figure 3 and Figure 4), we next 
examined whether CALHM2 could modulate the Ca2+ permeability of 
CALHM1 and CALHM3. We monitored [Ca2+]i of the HeLa cells transfected 
with GFP-tagged CALHM1 only or co-transfected with Myc-tagged 
CALHM2 in response to change of extracellular Ca2+ concentration from 0 to 
2 mM. We measured Ca2+ signals of the cells expressing GFP signals as 
similar levels between single and co-transfected conditions. Interestingly, we 
found that the increasing rate of [Ca2+]i in the CALHM1 and CALHM2 co-
transfected cells was 3 times slower than that in CALHM1 singly transfected 
cells: 4.43 ± 0.41 for CALHM1 and 1.41 ± 0.25 for CALHM1 and CALHM2 
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co-transfected cells (mean ± S.E.) (Figure 7A and 7C).  
The maximal [Ca2+]i was decreased by 2-fold in CALHM1 and CALHM2 
co-expressing cells than those in CALHM1 single expressing cells (Figure 
7D). We also examined the Ca2+-content within the ER of the doubly 
transfected cells. Although the Ca2+-content within the ER tended to be 
slightly increased in CALHM1 and CALHM2 co-expressing cells compared 
to CALHM1 expressing cells, however statistical significance could not be 
determined between them (Figure 7E). On the other hand, co-expression of 
CALHM2 with CALHM3 slightly but significantly increased the [Ca2+]i -
increasing rate by 2-fold and increased the maximal [Ca2+]i by 1.5-fold 
compared to CALHM3 single expression (Figure 7B and 7C). Curiously, the 
Ca2+-content of the ER was also significantly increased by CALHM2 co-
expression with CALHM3. These results suggest that CALHM2 interacts with 





CALHM1-P86L shows impaired channel activity and that activity 
is modulated by CALHM2.  
In order to see the effect of CALHM1 mutation (P86L) on Ca2+ regulation, 
we transfected HeLa cells with CALHM1-P86L and measured [Ca2+]i. To 
induce the Ca2+ influx from the PM, we transiently depleted external Ca2+ and 
monitored [Ca2+]i under HBSS containing 2 mM CaCl2. CALHM1-P86L 
expression showed significantly increased Ca2+ influx compared to the control 
cells (Figure 8B). The Ca2+-increasing rate and maximal [Ca2+]i at the steady 
state of CALHM1-P86L expressing cells were significantly increased (Figure 
8C and 8D) and ER Ca2+-content was decreased compared to the control cells 
(Figure 8E). However, these channel activities were decreased compared to 
CALHM1-WT as previously reported (Dreses-Werringloer, Lambert et al. 
2008; Moreno-Ortega, Ruiz-Nuno et al. 2010) (Figure 5 and Figure 8) 
We confirmed interaction between CALHM1-P86L and CALHM2 using 
co-immunoprecipitation assay (Figure 8A) and then examined weather 
CALHM2 also regulates channel activity of CALHM1-P86L. CALHM2 co-
expression with CALHM1-P86L decreased Ca2+-increasing rate from 
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0.355±0.14 to 0.99±0.12 (about 3-fold) and lowered the [Ca2+]i at the steady 
state from 0.52±0.04 to 0.25±0.30 (2-fold) compared to CALHM1-P86L 
single expression (Figure 8C and 8D). We also measured ER Ca2+-content and 
found that CALHM2 co-expression with CALHM1-P86L reduced ER Ca2+-
content compared to CALHM1-P86L single expressing cells (Figure 8E). 
These results indicated that CALHM-P86L decreased channel activity of 











       
 
 




(A) Cellular localizations of CALHM family proteins in HeLa cells that 
were singly transfected with GFP tagged-CALHM family proteins, 
respectively. Cells were stained with anti-GFP (green), anti-Calreticulin (red) 
and DAPI (blue). Scale bar, 20 μm (B) CALHM family proteins colocalize 
with each other in HeLa cells. Cells overexpressing GFP-tagged CALHM2 or 
CALHM3 (green) and myc-tagged CALHM1 or CALHM2 stained with anti-
Myc antibody (red). Scale bar, 20 μm.  
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Figure 3. CALHM family interacts with each other. 
(C) CALHM1 interacts with CALHM2 in HEK293T cells. The cells were 
transiently transfected with CALHM1-myc and CALHM2-GFP. 
Immunoprecipitated CALHM2-GFP was probed with anti-GFP antibody. (D) 
CALHM2 binds to CALHM3 in HEK293T cells. Cells were co-transfected 
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with CALHM2-myc and CALHM3-GFP. The immunoprecipitated CALHM2-
myc and CALHM3-GFP with anti-CALHM2 and anti-CALHM3 antibodies 
were probed with anti-GFP antibody. (E) Interaction between CALHM1 and 
CALHM3 in HEK293T cells that co-expressing CALHM3-myc and 
CALHM1-GFP. Immunoprecipitated CALHM1-GFP was probed with anti-






Figure 4. CALHM family subtypes are expressed in the brain.  
The mRNA expressions of all CALHM family subtypes in various region 






Figure 5. CALHM1 and CALHM3 are Ca2+ leaky channels.  
(A) Measurement of Ca2+ entry in HeLa cells expressing each CALHM family 
proteins in response to extracellular Ca2+ elevation. Change of intracellular 
Ca2+ levels (ΔR, delta fura-2 ratio 340/380) of HeLa cells expressing CALHM 
family proteins upon the external Ca2+ elevation from 0 mM (0 CaCl2) to 2 






Figure 5. CALHM1 and CALHM3 are Ca2+ leaky channels. 
 (B) and (C) Quantifications of Ca2+-increasing rate (ΔR/min) and the 
maximal [Ca2+]i at the steady state (ΔR). The results are shown as the mean ± 
S.E. of at least three independent experiments. The total cell numbers were 
122 (control), 120 (CALHM1), 58 (CALHM2), and 144 (CALHM3) cells, 






Figure 6. Overexpression of CALHM1 and CALHM3 decreases ER 
Ca2+ content of HeLa cells. 
(A) Change of [Ca2+]i in HeLa cells expressing CALHM family proteins 
upon CPA stimulation under Ca2+-free condition. The experiments were 
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performed at least three times and the representative results are shown. (B) 
ER Ca2+ contents of HeLa cells expressing CALHM family proteins. Ca2+ -
contents were expressed as area under curve (AUC) of Fura-2 ratio change. 
The results are shown as the mean ± S.E. of at least three independent 
experiments. The total number of cells were 91 (control), 41 (CALHM1), 36 








Figure 7. CALHM2 regulates CALHM1 and CALHM3 Ca2+ 
channel activity. 
(A) and (B) Ca2+ entry of HeLa cells transfected with CALHM1 or 
CALHM3 and co-transfected with CALHM2. The representative changes of 
[Ca2+]i upon external Ca2+ elevation from 0 mM (0 CaCl2) to 2 mM (2mM 





Figure 7. CALHM2 regulates CALHM1 and CALHM3 Ca2+ 
channel activity. 
(C) and (D) Quantifications of Ca2+ -increasing rate (ΔR/min) and the 
maximal [Ca2+]i at the steady state (ΔR). The total number of cells were 120 
(CALHM1), 48 (CALHM1 and CALHM2), 143 (CALHM3) and 151 
(CALHM3 + CALHM2) cells, respectively. (E) ER Ca2+-contents of 
CALHM1 or CALHM3-single expressing cells and CALHM2 co-expressing 
cells with CALHM1 or CALHM3. ER Ca2+ content was calculated by area 
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under curve (AUC) of CPA-induced fura-2 ratio change in the absence of the 
external Ca2+. The total number of cells were 41 (CALHM1), 54 (CALHM1 + 
CALHM2), 89 (CALHM3) and 81 (CALHM3 + CALHM2) cells, 
respectively. All results are shown as the mean ± S.E. of at least three 
independent experiments. **, p < 0.01; ***, p < 0.001. 
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Figure 8. CALHM2 interacts with CALHM1-P86L and modulates 
channel activity of CALHM1-P86L.   
(A) Interaction of CALHM1-P86L with CALHM2 in HEK293T cells. (B) 
Change of [Ca2+]i in HeLa cells that express CALHM1-P86L and co-
expression of CALHM1-P86L with CALHM2 upon extracellular Ca2+ 




Figure 8. CALHM2 interacts with CALHM1-P86L and modulates 
channel activity of CALHM1-P86L.   
 (C) and (D) Quantifications of Ca2+ -increasing rate (ΔR/min) and the 
maximal [Ca2+]i at the steady state (ΔR). The total number of cells were 122 
(control), 144 (CALHM1-P86L) and 97 (CALHM1-P86L + CALHM2) cells, 
respectively. (E) ER Ca2+ content of CALHM1-P86L expressing cells or 
CALHM1-P86L and CALHM2 co-expressing cells. Data were shown as AUC. 
The total number of cells were 81 (CALHM1-P86L) and 58 (CALHM1-P86L 
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+ CALHM2) cells, respectively. All results are shown as the mean ± S.E. of at 




Although CALHM2 and CALHM3 share sequence homology with 
CALHM1 and have transmembrane domains similar to CALHM1 (Hirokawa, 
Boon-Chieng et al. 1998; Dreses-Werringloer, Lambert et al. 2008), the 
precise nature of CALHM2 and CALHM3 has not been extensively analyzed 
yet. In this study, we first demonstrated that CALHM2 and CALHM3 are 
localized at the ER and the PM and expressed in various regions in the mouse 
brain as similar to CALHM1. CALHM3 had the leaky Ca2+ channel properties 
as a homomeric channel however CALHM2 didn’t show the Ca2+ channel 
activities. We also found that CALHM subtypes constitute heteromeric 
channels and that their mutual interactions differently modulate the channel 
activity of CALMH1 at the PM: CALHM2 reduces the Ca2+ permeability of 
CALHM1, whereas it increases that of CALHM3. Thus, our findings 
demonstrated a previously uncharacterized feature of CALHM families as 
heteromeric Ca2+ channels. 
It is interesting that homomeric CALHM2 channel is impermeable for Ca2+, 
whereas homomeric CALHM1 or CALHM3 exhibit the Ca2+ permeability. It 
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is known that CALHM1 has a short sequence within the COOH terminus of 
the hydrophobic domain 2 and has homology with the selectivity filter of the 
NMDA receptor (Dreses-Werringloer, Lambert et al. 2008). Accordingly, the 
asparagine 72 residue of CALHM1 was assumed to correspond critical 
residue for ion selectivity and permeation of NMDAR NR2 subunit 
(Wollmuth and Sobolevsky 2004) and was shown to be a key determinant in 
control of cytosolic Ca2+ levels (Dreses-Werringloer, Lambert et al. 2008). 
Therefore, we hypothesized that the difference of the amino acid residue 
might explain Ca2+ impermeability of CALHM2, however the corresponded 
asparagine residue is conserved for both CALHM2 and CALHM3. Thus, the 
difference of selective filter does not explain the Ca2+ impermeability of 
CALHM2. 
Alternative possibility is the difference of precise intracellular localization 
between CALHM2 and other subtypes. Although we revealed that CALHM2 
showed a similar pattern of intracellular localization as CALHM1 and 
CALHM3 by immunocytochemistry, we found the difference in the detergent 
solubility of CALHM2 as compared to CALHM1 and CALHM3: CALHM2 
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showed lower solubility for non-ionic detergent such as NP-40 and Triton X-
100 than CALHM1 and CALHM3 (our personal observation), suggesting the 
distinct localization of CALHM2 in the lipid microdomain called “raft”. It is 
known that membrane rafts affect various ion channels by regulating the 
gating kinetics and the trafficking and surface expression (Dart 2010). 
Therefore, raft resident proteins and/or raft-enriched lipids such as cholesterol 
and sphingolipids might directly or indirectly exert on the Ca2+ permeability 
of homomeric CALHM2 channels.  
In addition, we showed that CALHM2 regulates CALHM1 and CALHM3 
channel activities in heteromeric channels: CALHM1/CALHM2 heteromeric 
channel has a lower Ca2+ permeability than CALHM1 homomeric channel, 
whereas CALHM2/CALHM3 heteromeric channel showed higher Ca2+ 
permeability than CALHM3 homomeric channel. Besides change of the 
channel pore properties by heteromerization, heteromerization of CALHM 
subtypes might also control their distinct localization within the PM, resulting 
in modulation of the channel activities. 
The mutant form of CALHM1, CALHM1-P86L, was proposed to be an AD 
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risk factor (Dreses-Werringloer, Lambert et al. 2008; Boada, Antunez et al. 
2010; Cui, Zheng et al. 2010), however its association with AD is still 
controversial (Inoue, Tanaka et al. 2010; Shibata, Kuerban et al. 2010; Feher, 
Juhasz et al. 2011). CALHM-P86L has reduced Ca2+ permeability (Dreses-
Werringloer, Lambert et al. 2008) and shows slower cytosolic- and 
mitochondrial Ca2+ transients than those generated by CALHM1 (Moreno-
Ortega, Ruiz-Nuno et al. 2010).  In addition, CALHM-P86L was shown to 
increase the Aβ production (Dreses-Werringloer, Lambert et al. 2008). We 
examined whether CALHM2 regulates the CALHM1-P86L channel activity 
in a different way from wild-type CALHM1, but CALHM2 similarly 
interacted with CALHM1-P86L and inhibited the CALHM1-P86L channel 
activity. Therefore, the difference in the sensitivity of CALHM1-P86L for 
CALHM2 would not be directly associated with AD risk. However, because 
CALHM2 expression further decreases the Ca2+ permeability of CALHM1-
P86L that has the reduced Ca2+ permeability as compared to wild-type 
CALHM1, the CALHM2 interaction with CALHM1-P86L might further 
promote the Aβ production in the brain.  
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It is known that ER stress triggers unfolded protein response (UPR) to 
protect the ER, but prolonged ER stress ultimately leads to cell death (Doyle, 
Kennedy et al. 2011; Stefani, Wright et al. 2012). Disturbed Ca2+ homeostasis 
within the ER is one of the causes that trigger ER stress (Lindholm, Wootz et 
al. 2006; Doyle, Kennedy et al. 2011) and has been thought to be related with 
the pathogenesis of some neuronal disease such as Parkinson’s disease and 
AD (Katayama, Imaizumi et al. 2004; Lindholm, Wootz et al. 2006; Cali, 
Ottolini et al. 2011; Stefani, Wright et al. 2012). For example, many AD-
related PS mutations affect their ER Ca2+ leak function, leading to the Ca2+ 
overload within the ER (Tu, Nelson et al. 2006; Supnet and Bezprozvanny 
2010; Supnet and Bezprozvanny 2011).  
Recently, it was reported that CALHM1 decreases Ca2+-contents within the 
ER, which causes ER stress (Gallego-Sandin, Alonso et al. 2011). Since 
CALHM3 overexpression decreased Ca2+ stores within the ER, CALHM3 
expression might also induce ER stress. In addition, we also showed that 
heteromelization of CAHLM3 with CALHM2 modulates the Ca2+ contents 
within the ER. Because the balance between Ca2+ influx and Ca2+ efflux from 
４４ 
 
the ER is important for determining the Ca2+ store size, the ratio change of 
hetero- and homomers of CALHM1 in the brain would affect Ca2+ store size 
and the subsequent ER stress. Further study, e.g. expression level of each 
CALHM subtypes in distinct neurons and regulation of their expression 
profile of CALHM family proteins in the pathological conditions of the brain 
will be an interesting issue to reveal as the physiological role of the 
heteromeric CALHM channels in the brain.  
In summary, CALHM family proteins interact with each other and 
constitute heteromeric Ca2+ channels. Through these interactions, CALHM2 
regulates channel activities of CALHM1 and CALHM3 and affects the 
intracellular and the ER Ca2+ concentration. We propose that regulation of 
Ca2+ signaling by heteromeric CALHM family proteins may provide new 
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칼슘이온은 세포의 생존에 필수적인 물질로서 세포는 
칼슘항상성을 유지하며 다양한 기능을 수행하고 있다. 특히 
신경세포 내에서 칼슘은 세포막의 흥분성, 시냅스 전달과정 
등과 같은 주요한 기능을 조절하는데 중요한 역할을 하고, 
칼슘 항상성의 저해는 알츠하이머 병과 같은 신경퇴행성 
질환과 관련되어 있음이 보고되고 있다.     
Calcium homeostasis modulator 1 (CALHM1)은 leaky 칼슘 
채널로서, 주로 소포체 막에 존재하며 세포막에도 일부 존재 
하면서 세포 내의 칼슘 농도를 조절한다. CALHM1 의 
돌연변이형인 CALHM1-P86L 은 알츠하이머 병의 원인 
유전자로서 처음 보고되었지만 그 관련성에 대해서는 
상반되는 결과들이 발표되고 있다.   
또 다른 CALHM family단백질로는 CALHM2와 CALHM3가 
알려져있는데, 이들의 기능에 대해서는 거의 보고된 바가 없다. 
하지만 CALHM family 단백질들은 서로 비슷한 아미노산 
서열을 가지고 있으며 구조적으로도 3 개 또는 4 개의 막 통과 
부분을 가지는 유사성을 보이기 때문에 본 연구에서는 전체 
５１ 
 
CALHM family 단백질이 칼슘 채널로서 작용할 수 있는 
가능성과 이들간의 상호작용에 주목하였다.  
그 결과 세포 내에서 CALHM family 단백질들간의 
상호작용을 확인하였고, CALHM3 는  CALHM1 과 유사한 
방법으로 세포 내에서 leaky 칼슘 채널로서 작용하는 것을 
처음으로 관찰하였다. CALHM2 는 그 자체로는 채널로서의 
기능을 보이지 않았지만 CALHM1 또는 CALHM3 와 함께 
발현시켰을 경우에는 이들 자체의 채널기능을 변화시켰다. 
이러한 결과들을 통해 본 연구는 칼슘 신호전달 과정의 
새로운 메커니즘을 제시하였으며 CALHM family 단백질들이 
실재 뇌에서 heteromeric 채널로서 세포 내 칼슘 항상성을 
조절하는데 기여할 수 있는 가능성을 보여주었다.  
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